Summary of Purpose
- Aphasia, the loss or impairment of language caused by brain damage, is one of the most devastating cognitive impairments of stroke. Aphasia can be treated with combination of speech-language therapy and drugs. Conventional speech-language therapy in chronic aphasic subjects is of little help and several drugs have been studied with limited success. Therefore other therapeutic strategies are...Read More →
The following dates are available for this trial. Trial information last updated on 12 September 2005.
|1 Mar 2005||12 Sep 2005||Unavailable||1 Sep 2005||1 Mar 2005||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Allocation: Randomized
- Masking: Double-Blind
- Purpose: Treatment
- Endpoint: Safety/Efficacy Study
- Intervention: Parallel Assignment
- Marcelo L. Berthier, M.D., Ph.D.